Viking Therapeutics Unusual Options Activity For March 19
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) has seen significant options trading activity, with a bullish sentiment prevailing among financial giants. Analysis of 18 unusual trades revealed 61% bullish and 38% bearish tendencies, with a notable interest in calls over puts. The trading range for VKTX is predicted between $5.0 and $90.0. Recent analyst ratings have varied, with an average target price of $95.0, though one analyst from Stifel downgraded the stock to Buy with a target price of $80. VKTX's current trading volume is 716,356, with a slight price decrease of -0.79%, now at $62.85. The stock's RSI indicates a neutral position, and its earnings release is anticipated in 36 days.
March 19, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Viking Therapeutics has seen bullish options activity and mixed analyst ratings, with a current slight price decrease and neutral RSI. Earnings are anticipated in 36 days.
The bullish options activity, combined with the anticipation of earnings release and the current neutral RSI, suggests a potential short-term upside for VKTX. However, the slight price decrease and mixed analyst ratings introduce some uncertainty, hence the importance and confidence scores.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100